5 Most Promising Psychedelic Stocks According to Hedge Funds

Page 1 of 5

In this piece, we will take a look at the five most promising psychedelic stocks according to hedge funds. If you want to learn more about how the landscape around psychedelics is changing, then read 11 Most Promising Psychedelic Stocks According to Hedge Funds.

5. Relmada Therapeutics, Inc. (NASDAQ:RLMD)

Number of Hedge Fund Investors In Q3 2023: 13

Relmada Therapeutics, Inc. (NASDAQ:RLMD) is a biotechnology company developing treatments for major depressive disorder. The firm’s third quarter earnings saw management tout the benefits of psilocybin in low doses to treat liver disorders – which is a rather unique application of psychedelics.

By the end of Q3 2023, 13 out of the 910 hedge funds covered by Insider Monkey’s research were Relmada Therapeutics, Inc. (NASDAQ:RLMD)’s shareholders. David Kroin’s Deep Track Capital was the largest shareholder as it owned $8.5 million worth of shares.

Follow Relmada Therapeutics Inc. (NASDAQ:RLMD)

Page 1 of 5